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Abstract 
Infectious myonecrosis virus (IMNV) causes significant economic losses in farmed shrimp, where 
associated mortality in ponds can reach 70%. To explore host/pathogen interactions, a next-generation 
sequencing approach using lymphoid organ tissue from IMNV-infected Litopenaeus vannamei shrimp 
was conducted. Preliminary sequence assembly of just the virus showed that there were at least an 
additional 639 bp at the 5′ terminus and 23 nt at the 3′ terminus as compared with the original de-
scription of the IMNV genome (7561 nt). Northern blot and reverse transcription-PCR analysis con-
firmed the presence of novel sequence at both ends of the genome. Using 5′ RACE, an additional 4 
nt were discovered; 3′ RACE confirmed the presence of 22 bp rather than 23 bp of sequence. Based 
on these data, the IMNV genome is 8226 bp in length. dsRNA was used to trigger RNA interference 
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(RNAi) and suppress expression of the newly revealed genome sections at the 5′ end of the IMNV 
genome in IMNV-infected L. vannamei. An RNAi trigger targeting a 376 bp length of the 5′ UTR did 
not improve survival of infected shrimp. In contrast, an RNAi trigger targeting a 381 bp sequence in 
ORF1 improved survival to 82.2% as compared with 2.2% survival in positive control animals. These 
studies revealed the importance of the new genome sections to produce high-titre infection, and as-
sociated disease and mortality, in infected shrimp. 
 
Introduction 
 
A large number of pathogens threaten the shrimp aquaculture industry with a majority of 
these being viral in aetiology. The total economic impact is significant, with losses in the 
billions of dollars (Lightner et al., 2012). The emergence of novel pathogens is inevitable 
because of the combined effects of high-intensity farming, and a globalized aquaculture 
industry that exports and imports either live or unprocessed products, and thereby rapidly 
disseminates pathogens worldwide. The emergence of infectious myonecrosis virus 
(IMNV) is thought to have occurred via international transport of live animals (Senapin et 
al., 2007). IMNV was first reported in Brazil in 2003 after a disease outbreak occurred in 
2002 (Poulos et al., 2006) and then an outbreak occurred in Indonesia in 2006 where it 
caused devastating economic losses (Senapin et al., 2007). Clinically, IMNV-infected ani-
mals demonstrate lethargy and the appearance of white muscle that spreads from the sixth 
abdominal segment; this pathology in individuals is an indicator for IMNV-induced mor-
tality in ponds that can reach 70% (Senapin et al., 2007). 
IMNV is an unenveloped, nonsegmented, dsRNA virus with icosahedral symmetry and 
complex protrusions at the fivefold symmetry axis that are thought to be involved in virus 
entry (Tang et al., 2008). IMNV is classified in the family Totiviridae based on its genomic 
organization and significant amino acid identity to the genome of a strain of Giardia lamblia 
virus, specifically in the RNA-dependent RNA polymerase (RdRp) gene (Poulos et al., 
2006). The IMNV genome encodes two ORFs. ORF1 is translated into a polyprotein that is 
processed into three smaller proteins, the functions of which remain undetermined, via 
“2A-like” cleavage sites (Nibert, 2007; Tang et al., 2008) and also encodes the major capsid 
protein (MCP). ORF2 encodes the RdRp. Another protein (the MCP–RdRp fusion protein) 
is translated by virtue of a –1 frameshift within ORF1 (Nibert, 2007; Poulos et al., 2006). 
The IMNV genome was initially reported to be 7561 bp in length (GenBank accession 
number EF061744.2) (Poulos et al., 2006). Although the reported IMNV genome size was 
approximately in the size range of members of the family Totiviridae (5.0–7.0 kbp), the 
published IMNV sequence did not appear to have a predicted internal ribosomal entry site 
(IRES) in its 5′ UTR that is characteristic of viruses in this family (Garlapati & Wang, 2005). 
In addition, some protein bands observed from purified IMNV virions did not match the 
sizes of the predicted cleavage products from the ORF1 polypeptide (Tang et al. 2008). 
To explore shrimp/virus interactions, we undertook a next-generation sequencing 
(NGS) approach using lymphoid organ tissues. The penaeid shrimp lymphoid organ is 
located at the anterior end of the shrimp on the rostral/ventral side of hepatopancreas. The 
function of the lymphoid organ is, in part, removal of pathogens from haemolymph during 
circulation. Furthermore, the lymphoid organ is a common site for virus replication and 
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associated pathology (e.g., spheroids) to occur (Assavalapsakul et al., 2006; Escobedo-
Bonilla et al., 2007). Lymphoid organ tissues express a significant number of immune-related 
genes in normal and infected shrimp (Pongsomboon et al., 2008). It follows that this is a 
lead tissue in which to explore IMNV RNA production and breakdown during an active 
IMNV infection. Using an NGS approach to study mRNA production in the lymphoid or-
gan, we identified a substantial amount of virus genome sequence that extended beyond 
the original genome description. This additional sequence appeared to include sequence 
that is key to virus replication. 
 
Results and Discussion 
 
IMNV sequencing analysis 
A total of 43 567 120 trimmed 50 bp reads were obtained from IMNV-infected L. vannamei 
and used for sequence assembly. To identify IMNV sequence, each of the contig sets was 
aligned to the existing IMNV sequences. Two IMNV contigs were identified: one 8044 bp 
in length and another of 8223 bp. Both contigs were significantly longer in size than that of 
the originally published IMNV sequence (7561 nt, Genbank accession number EF061744.1). 
A sequence alignment revealed that 662 bp of new, putative IMNV sequence was not 
within the limits of the known sequence but fell primarily upstream of the 5′ end (639 bp) 
and, to a more limited extent, at the 3′ end (23 bp) of the genome (Fig. S1). 
 
New 5′ end and known IMNV sequences have an equal depth of sequencing 
RNA sequencing reads that represented IMNV sequences were subjected to de novo as-
sembly and mapped across the length of the genome (Fig. 1). Sequence coverage of the 
new sequences and the previously published sequences is listed in Table 1. Although there 
were significant variations in the sequencing depth at specific nucleotide locations in the 
IMNV genome (Fig. 1), the mean sequencing coverage between the new and known se-
quences (Table 1) was similar, suggesting that the new sequences were equally represented 
in the cDNA library. 
 
Table 1. Comparison of sequencing coverage between the new (current) IMNV genome sequence 
produced by Illumina sequencing and previously published IMNV sequences (see also Fig. 1) 
 Sequencing coverage (fold) 
IMNV sequence Positive strand Negative strand Overall 
Current IMNV genome (8223 bp) 29.39 26.21 55.60 
5′ Current IMNV (639 bp) 26.37 21.48 47.85 
Original IMNV genome (7561 bp) 29.73 26.67 56.40 
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Figure 1. Sequencing coverage of IMNV genomic sequences. Illumina reads from IMNV-
infected shrimp that represent IMNV sequence were mapped to the assembled IMNV se-
quence using a custom-designed Perl program. Sequencing coverage was calculated ac-
cording to the numbers of times each base mapped to the IMNV genome. New sequence 
is delineated with a vertical line at the position where the original 7561 bp sequence 
started or stopped at the 5′ and 3′ ends, respectively (see also Figs. S1 and S4). 
 
Confirmation of presence of sequence in IMNV Indonesia and Brazil 
Deep-sequencing results indicated that there were at least an additional 639 nt at the 5′ end and 
23 nt at the 3′ end when compared with the previously published IMNV genome sequences. 
Several sets of primers were designed to confirm these novel IMNV sequences in isolates 
from Indonesia and Brazil. Four sets of primers were used to confirm the 5′ end by reverse 
transcription (RT)-PCR, including IMNV26F, IMNV312F, IMNV643R, and IMNV1016R 
(Table S1). Previously published primers (95F and 475R) that amplified the known genome 
sequence were used as positive controls (Table S1). RTPCR amplicons were subjected to 
gel electrophoresis and sequence length was confirmed (Fig. S2, lane 1–4). The largest am-
plicon (990 bp, Fig. S2, lane 4) was cloned and sequenced, and had 95 % nucleotide identity 
compared with published sequences. These primer pairs also were tested with IMNV Bra-
zil, and RT-PCR results were identical to those for IMNV Indonesia (Fig. S2, lanes 5–8), 
and sequenced PCR products had 100 and 99% nucleotide identity to IMNV Brazil and 
Indonesia, respectively. 
Two reverse primers (IMNV8204R1 and IMNV8204R2) were designed to anneal the 
newly discovered sequence, in combination with forward primers designed to previously 
known sequence at the 3′ terminus (Table S1). The novel sequence was confirmed in both 
IMNV strains using these primers (Fig. S3). These data did not prove that the sequence at 
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the 3′ end of the genome strains is identical in the two strains, but amplification did indi-
cate that additional sequence at the 3′ terminus is indeed incorporated into IMNV virions. 
 
IMNV genome size determination and Northern blot analysis 
Gel electrophoresis was used to further confirm the size of the IMNV genome. A distinct 
band was evident at ~8–9 kb (Fig. 2). Total RNA from purified IMNV virus and noninfected 
shrimp was subjected to Northern analysis with RNA probes that were generated to anneal 
to the old sequence and new sequence. Again, a band of ~8–9 kb was detected in extracted 
RNA from IMNV-infected shrimp using probes designed to the original and new IMNV 
sequence (Fig. 3). These results further confirmed that the novel sequence discovered by 
deep sequencing existed in IMNV viral genome. 
 
 
 
Figure 2. Northern analysis of IMNV novel and previously known sequence. RNA from 
L. vannamei was subjected to electrophoresis on a denaturing 1% agarose glyoxal gel. In 
each lane, 5 mg total RNA was loaded from uninfected (U) shrimp tissues or from clarified 
IMNV-infected (I) shrimp tissues. RNA loading is shown in the ethidium bromide-labeled 
gel image to the left of each hybridized blot. To detect the presence of IMNV, RNA was 
subjected to hybridization with probes to specific genome locations of interest, including 
the original genome with 95 (sense, 95F) and 475 (antisense, 475R) probes. Novel genome 
sequence was detected using 233 (sense, 233F) and 613 (antisense, 613R) probes, as labeled. 
Lane 1 was loaded with 0.5–9 kb (RNA) Millennium Marker (Ambion). 
  
L O Y  E T  A L . ,  J O U R N A L  O F  G E N E R A L  V I R O L O G Y  9 6  (2 0 1 5 )  
6 
 
 
Figure 3. Sequence length analysis of the IMNV genome. IMNV RNA purified from 
shrimp tissues (IMNV, lane 1), and RNA from uninfected L. vannamei (L.v., lane 2) were 
subjected to electrophoresis on a denaturing 0.8% agarose glyoxal gel containing ethidium 
bromide. Markers to determine the molecular weight of RNA include the 0.5–9 kb (RNA) 
(Millennium Marker Ambion) (left) and 0.5–10 kb RNA ladder (Invitrogen) (right). 
 
5′ and 3′ RACE PCRs to confirm the presence of additional nucleotides in the IMNV genome 
To validate the new IMNV sequence identified by NGS, 5′ and 3′ RACE PCRs were per-
formed. Fourteen PCR products generated from 5′ RACE of cDNA from IMNV Indonesia 
were sequenced; sequence analysis confirmed the presence of 639 bp identified by NGS 
and added an additional 4 bp upstream. These additional 4 bp were present both in IMNV 
Indonesia and Brazil. All told, 5′ RACE PCR confirmed that the IMNV sequences previ-
ously published and submitted to GenBank (accession numbers NC_007915.2, AY570982.2, 
and EF061744.1; 7561 bp) were truncated at the 5′ terminus by 643 bp. 
As the IMNV genome is not polyadenylated, a synthetic poly(A) tail was added to the 
3′ end and then 3′ RACE experiments were performed to confirm the presence of additional 
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sequence at the 3′ terminus of the genome. Ten PCR products were generated and se-
quenced using 3′ RACE for IMNV Brazil. These experiments confirmed that an additional 
22 bp were present at the distal 3′ end, supporting the findings from the NGS analysis. We 
were unable to generate any positive clones in the 3′ RACE experiments performed with 
IMNV Indonesia. However, we were able to amplify and sequence the 3′ end of IMNV 
Indonesia using IMNV7852F as the forward primer and IMNV8210R2 as the reverse pri-
mer; the sequence of the latter primer corresponded to the distal 22 bp of the 39 UTR of 
IMNV Brazil (Table S1). These data indicated that an additional sequence was present at 
the 3′ end of the genome in both virus strains. Therefore, using 5′ and 3′ RACE, we con-
firmed the presence of the nucleotide sequences identified by NGS at the 5′ and 3′ ends of 
the IMNV genome, and revealed the presence of an additional 4 nt at the distal 5′ end. The 
full-length 8226 bp genomic sequence of IMNV was submitted to GenBank (accession 
numbers KF836757 and KJ556923). 
 
Analysis of the newly identified sequence at the 59 end of the IMNV genome 
The IMNV sequence is nonsegmented and encodes two predicted ORFs. To clarify whether 
the newly revealed 639 nt at the 5′ end of the genome encoded protein sequences, we trans-
lated the total length of the IMNV genome in silico in all six frames (Fig. S4). The predicted 
translation analysis showed that the longer IMNV genome encoded two predicted ORFs. 
The longer genome produced a predicted ORF1 in frame 1 that comprised 1719 aa, which 
was 114 aa larger than the previously published predicted product of ORF1 (1605 aa). The 
predicted start codon of the new ORF1 was 342 nt upstream of the documented start codon. 
Fig. S1 shows the new N-terminal sequence and alignment of the new N-terminal se-
quences and the published sequences of the IMNV ORF1. The ORF2 (frame 3) is almost 
identical to the previously predicted ORF2 protein sequence. With a new understanding 
of the coding region, the secondary RNA structure of the 5′ UTR sequence was predicted 
using RNAfold. The resulting predicted 5′ UTR RNA structure was then compared with 
known IRES structures (using IRESite and IRSS). There was no significant homology with 
known viral IRES elements; however, the IRES elements of viruses in the family Totiviridae 
do not always fall strictly in the 5′ UTR, and are characterized by multiple complex sec-
ondary RNA structures and multiple, noninitiating AUG codons (Garlapati & Wang, 
2005). The predicted 5′ UTR structure of IMNV contains several stem-loop structures and 
multiple AUG codons. 
In a previously published analysis of the translation productions of IMNV ORF1, two 
“2A-like” peptide cleavage motifs were described (Nibert, 2007), along with a cleavage site 
that cleaves the C terminus of ORF1 to release the MCP. These three cleavage motifs hy-
drolyze the ORF1 polyprotein into four predicted products: the N-terminal peptide 1 (10 
kDa), peptide 2 (31 kDa), predicted peptide 3 (36 kDa), and the C-terminal 99 kDa MCP 
(Fig. S4). ORF2 (frame 3) is translated by –1 frameshifting of ORF1 and produces a 196 kDa 
MCP-RdRp fusion (Nibert, 2007; Poulos et al., 2006; Tang et al., 2008). Indeed, Tang et al. 
(2008) showed that when purified IMNV virions were separated by SDS-PAGE and 
stained, five clear protein bands were evident. Two bands at 99 and 196 kDa corresponded 
to MCP and MCP-RdRp, respectively. The remaining three bands were between 25 and 40 
kDa (Tang et al., 2008). A 10 kDa peptide (the predicted size of peptide 1 of ORF1) was 
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never observed. The newly revealed genome sequence explained this discrepancy because 
it extended the N terminus of peptide 1 to 207 aa, with a predicted molecular mass of 23 
kDa. Therefore, it is likely that the 25 kDa protein observed previously was the full-length 
peptide 1, and the other two bands represented peptides 2 (31 kDa) and peptide 3 (36 kDa) 
(Tang et al., 2008). 
 
dsRNA targeting novel IMNV genome sections provides protection against infectious 
myonecrosis disease 
In order to begin to test the biological relevance of the novel sequences at the 5′ terminus 
of IMNV, two dsRNAs (designated dsRNA26-401 and dsRNA233-613; Fig. S4) were de-
signed and compared with dsRNA95-475, which targeted the previously known coding 
region of peptide 1. dsRNA95-475 provided significant disease protection [81.67 % survival 
against IMNV at 30 days post-infection (p.i.)] when animals were subjected to the dsRNA 
prior to infection (Loy et al., 2012). For comparative purposes, dsRNAs to the novel IMNV 
sequence were designed to have a similar length to dsRNA95-475. Shrimp were injected 
with 5 mg per shrimp (100 ml) of either dsRNA26-401, dsRNA233-613, dsRNA95-475, 
dsEGFP or 2% NaCl (sham inoculation), held for 48 h and then infected with IMNV (1:100 
dilution) by injection at 48 h. Negative control shrimp were injected with 2% NaCl (virus 
diluent) rather than virus. In three separate trials, significant mortality was observed in 
shrimp exposed to dsRNA26-401, dsEGFP, or sham inoculation with 3.3, 2.2, and 2.2% 
mean survival, respectively. In contrast, shrimp that received dsRNA233-613 and 
dsRNA95-475 showed similar protection against IMNV with mean survival of 82.2 and 
97.8%, respectively, at 14 days p.i. (Fig. 4). Mean survival for dsRNA233-613 and 95-475 
was significantly different from the other groups (dsEGFP, dsRNA26-401, and positive 
control) (Pv0.001) using one-way ANOVA followed by Tukey’s multiple comparison test. 
All of the negative control animals (nonchallenged) survived during the experiments. 
Therefore, only dsRNA233-613 showed protection against IMNV, and the protection effi-
cacy was comparable with dsRNA95-475. This differential effect of RNAi triggers on 
IMNV virus load and virus-induced pathology is in keeping with a previous study 
wherein we showed that dsRNA targeting in ORF1 within the peptide-1-encoding region 
provided maximum protection from morbidity and mortality (Loy et al., 2012). dsRNA233-
613 does encompass a region of the predicted ORF1 and dsRNA26-401 falls exclusively in 
the 5′ UTR (Fig. S4). ORF1 contains a dsRNA-binding protein domain; in a previous study, 
a dsRNA (dsRNA95-475) that also targeted the peptide-1-coding region was the most ef-
fective antiviral dsRNA tested, as compared with dsRNAs that targeted the MCP and 
RdRP (Loy et al., 2012). 
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Figure 4. Shrimp survival post-administration with novel dsRNAs (dsRNA26-401 and 
dsRNA233-613) compared with previously reported dsRNA (dsRNA95-475) and heterol-
ogous dsRNA (dsEGFP) post 48 h IMNV infection. Data represent mean ± SEM; n = 90 
animals per treatment except for the negative control group, n = 30 animals. 
 
Novel IMNV dsRNA inhibition of IMNV replication 
Virus load was analyzed by quantitative real-time (qRT)-PCR on muscle tissues from dead 
animals in dsRNA26-401, dsEGFP, and positive control groups at 9–14 days p.i., and the 
surviving animals from the dsRNA233-613 and dsRNA95-475 groups at 14 days p.i. The 
results showed that dsRNA95-475 and dsRNA233-613 inhibited virus replication [mean 
4.47 × 102 and 2.90 × 103 virus copies (μl RNA)–1, respectively] and virus load in these ani-
mals was significantly different from that in the positive control group (mean 1.1 × 105 
virus copies (μl RNA)–1) (P = 0.013 and P = 0.016, respectively). By contrast, dsRNA26-401 
and dsEGFP-exposed shrimp did not show reduction of virus (mean 4.77 × 104 and 7.72 × 
104 virus copies (μl RNA)–1, respectively) (Fig. S5). This was further evidence that 
dsRNA233-613 suppressed virus replication during IMNV infection. 
In conclusion, new genome sections of IMNV were discovered using deep sequencing 
of the lymphoid organ from infected L. vannamei. Based on these data, and 5′ and 3′ RACE, 
the genome sequence of IMNV is 8226 bp in length, as compared with the original under-
standing of a 7561 bp genome. This new sequence represents sections that expand the pre-
dicted coding region of ORF1 by 114 aa and add an additional 23 nt at the 3′ end. The 
presence of these genome sections was confirmed by RT-PCR, RACE PCR, and Northern 
blotting. RNAi triggers were developed to specifically target the new 5′-most sequence, 
including one trigger that falls on sequence that represents just the 5′ UTR, and one that 
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encompasses some of the 5′ UTR and some of the predicted coding region of ORF1, peptide 
1. The latter of these provided significant protection from IMNV challenge manifest as sig-
nificantly higher survival, decreased pathology, and a reduction in viral replication com-
pared with the RNAi trigger that targets just the 5′ UTR. This discovery provides an 
opportunity to further understand the function of the peptides encoded at the N terminus 
of ORF1, as well as novel targets for RNA-based vaccines and antivirals. 
 
Methods 
 
Shrimp culture 
Specific-pathogen-free (SPF) L. vannamei were acquired from Shrimp Improvement Sys-
tems and maintained in a SPF, biosecure facility at Iowa State University. Post-larvae were 
placed in 1,000 liter fiberglass tanks filled with artificial sea water. Water conditions were 
maintained at 25–27°C, 30–35 parts per thousand salinity, with constant airstone aeration. 
Each tank was maintained with a carbon filter and an oyster shell airlift biofilter. Water 
quality was measured according to ammonia and nitrite levels (Nitriver3; Hach); temper-
ature and salinity were measured daily. 
 
IMNV Indonesia-infected lymphoid organs 
IMNV-infected tissues used for this study were collected during an IMNV outbreak in In-
donesia. The virus inoculum was prepared as described previously (Loy et al. 2012). Six 
shrimp (15–20 g) were infected by intramuscular injection with IMNV (strain Indonesia). 
Virus stock was prepared and diluted in 1:100 2% NaCl [~2.11 × 103 viral copies (μl RNA)–1] 
and filter-sterilized. Control shrimp were injected with 2% NaCl (viral diluent), as reported 
by Loy et al. (2012). 
Lymphoid organ tissues were collected from IMNV-infected animals at 5 days p.i. or 
from normal control shrimp at the same time. Gross organ characteristics were confirmed 
via light microscopy on a dissecting microscope. All lymphoid organs were preserved in 
RNAlater RNA Stabilization Reagent (QIAGEN) and stored at –80°C. Samples were then 
transferred to 750 μl TRIzol LS (Invitrogen) and processed for RNA extraction. Residual 
DNA was removed from the extracted RNA using a TURBO DNA-free kit (Ambion). RNA 
integrity was determined using an Agilent 2100 Bioanalyzer. Total RNA from five or six 
individual animals was pooled and diluted in nuclease-free water to achieve a concentra-
tion of 0.1 μg ml–1. cDNA libraries were prepared from pooled RNA samples using a 
TruSeq RNA Sample Prep kit (Illumina) following the manufacturer’s instructions. 
 
Illumina sequencing, sequence assembly and sequencing data processing 
cDNA libraries were subjected to 50 nt (single-end) sequencing using the HiSeq 2000 plat-
form (Illumina). Raw sequencing reads were obtained and trimmed to remove adaptor 
sequences, empty reads and low-quality sequences using the FAST-X toolkit (http://han-
nonlab.cshl.edu/fastx_toolkit/). These reads were assembled using Velvet (version 1.2.08) 
(Zerbino & Birney, 2008). The performance of Velvet assemblies is determined by hash 
length (k) and coverage cut-off (c). An iterative process was used to select the optimum k 
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and c values to produce the best assembly (Liu et al., 2011). The parameters used for as-
sembly of contigs were k = 31 and multiple c (c = 2–10). To identify contigs derived from 
IMNV sequences, the resulting contig sets (≥ 100 nt) were aligned against IMNV genomic 
sequences by running BLAST (Altschul et al., 1990). To determine IMNV sequencing cov-
erage, transcriptomic reads were clustered using the FAST-X toolkit, and clustered reads 
were subsequently mapped to the IMNV genome using a custom-designed Perl program. 
The Perl script was designed to allow mapping only once to the reference sequence, with 
no mismatched residues allowed. The number of reads that mapped to each nucleotide 
position was used to calculate coverage (fold) of each nucleotide. 
A biological sequence alignment editor (BioEdit version 7.1.11; (http://www.mbio.ncsu.edu/ 
bioedit/page2.html) was used as a platform for basic sequence manipulations of IMNV 
(e.g., sequence alignment, protein translation, ORF prediction, etc.). ClustalW2 was used 
for multiple sequence alignment (Larkin et al., 2007). 
 
Identification of sequences at the 5′ and 3′ ends of the IMNV genome by RT-PCR 
Oligonucleotide primers were designed to amplify novel IMNV sequence at both the 5′ 
and 3′ end of the genome (Table S1). Total RNA was extracted from shrimp inoculated 
with the Indonesia or Brazil strains of IMNV using TRIzol LS (Invitrogen). A one-step RT-
PCR kit (QIAGEN) was used with the following amplification parameters: 50°C for 30 min, 
95°C for 15 min and 35 cycles of 95°C for 15 s, 55°C for 30 s and 72°C for 45 s, followed by 
a final elongation at 72°C for 5 min. RT-PCR products were cloned into the pCR 2.1 vector 
(TOPO TA Cloning kit; Invitrogen) and transformed into Escherichia coli (One Shot TOP10; 
Invitrogen). Cells were grown on Luria-Bertani agar containing kanamycin (50 μg ml–1). A 
subset of colonies was screened for the presence of the desired insert by PCR, and these 
inserts were then purified and sequenced with vector-specific primers (M13F and M13R) 
using a 3730xl DNA sequencer (Applied Biosystems) at the Iowa State University DNA 
facility. 
 
RACE PCR 
 
5′ RACE PCR 
To identify the nucleotide sequences at the 5′ end of the IMNV genome sequence, 5′ RACE 
was conducted. Total RNA (1 μg) was reverse transcribed using the appropriate primer 
(452R for IMNV Indonesia and 163R for IMNV Brazil) and the resulting cDNAs were pu-
rified using a Purelink Quick PCR Purification kit (Invitrogen). Oligo(dC) tails were added 
to the 3′ end of 2 μg purified cDNA using 15 U terminal deoxynucleotidyltransferase (Invi-
trogen), 1 mM dCTP and 50 μg BSA ml–1 in 1× tailing buffer (100 mM potassium cacodylate, 
pH 7.2, 2 mM CoCl2 and 0.2 mM DTT). Tailing reactions were performed at 37°C for 30 
min and heat inactivated at 65°C for 10 min. C-tailed products were purified then PCR 
amplified using a consensus forward primer specific to the C-tailed termini (C tail F) and 
one of several reverse primers specific to the IMNV cDNA sequences (428R for IMNV In-
donesia and 243R for IMNV Brazil). The resulting products were cloned and transformed 
into competent E. coli cells. Selected colonies were screened by PCR using both vector-
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specific primers (M13F and M13R) and IMNV-specific primers (273F, 428R for IMNV In-
donesia and 51F, 243R for IMNV Brazil). Select amplicons were purified (QIAquick PCR 
purification kit; QIAGEN) and sequenced with an IMNV-specific reverse primer (374R for 
IMNV Indonesia and 304R for IMNV Brazil). 
 
3′ RACE PCR 
To identify the nucleotide sequences at the 3′ end of the IMNV genome, synthetic poly(A) 
tails were added to 10 μg IMNV RNA using 6 U poly(A) polymerase A (Ambion) in 1× 
reaction buffer (40 mM Tris/HCl, pH 8.0, 10 mM MgCl2, 2.5 mM MnCl2, 250 mM NaCl, 50 
mg BSA ml–1 and 1 mM ATP). Tailing reactions were incubated at 37°C for 1 h and then 
placed at –20°C for 2 min to inactivate the enzyme. Reaction products were purified by 
ethanol precipitation and poly(A)-tail-enriched RNAs were reverse transcribed using a re-
verse primer specific to the poly(A) tail (3′ RT). Resulting cDNAs were then PCR amplified 
using the appropriate primers (IMNV7852F and 3′Rev). PCR products from the 3′ RACE 
were also cloned and screened with gene specific primers (IMNV7852F and 3′Rev) and 
plasmid primers (M13F and M13R), and then sequenced with 7945F for both IMNV strains. 
 
dsRNA synthesis 
Two dsRNAs, each ~381 bp in length, were generated in the 639 bp of newly discovered 
sequence at the 5′ end of the IMNV genome. Primers for dsRNA synthesis were deigned 
to amplify from positions 26 to 401 (IMNV26T7F and IMNV401T7R) and 233 to 613 
(IMNV233T7F and IMNV613T7R) (Table S1, Fig. S4). The aforementioned dsRNAs were 
nearly identical in size to dsRNA95-475 (with the nucleotide range dictated by the position 
on the original IMNV genome sequence), which had proven protective effect in suppress-
ing IMNV replication. dsRNA95-475 of IMNV original sequences was generated according 
to a previous study (Loy et al., 2012). dsRNA was synthesized using the Ambion Megascript 
RNAi kit according to the manufacturer’s instructions. Briefly, a PCR was run containing 
primers with T7 sequences added to the 5′ terminus of primers (Table S1). Complementary 
DNA was generated following the manufacturer’s instructions for ThermoScript RT (Invi-
trogen) using total RNA extracted from IMNV-infected shrimp and forward primer IMNV26F. 
PCR was performed using PCR master mix (PuReTaq Ready-To-Go PCR Beads; GE 
Healthcare), cDNA template and the primers containing T7 extensions that were designed 
to specific regions of the new IMNV genome. PCR products were purified using a QIAquick 
PCR purification kit (QIAGEN), concentrated using a vacuum concentrator and 1 μg was 
added to an in vitro transcription reaction. The synthesis reaction was incubated at 37°C 
for 12–16 h, and then treated with RNase and DNase I. The formation of dsRNA was con-
firmed by 1% agarose gel electrophoresis and quantified by spectrophotometry (NanoDrop 
2000; Thermo Scientific). The dsRNAs were stored in –20°C until use and were then diluted 
in RNase-free water to produce the desired concentration. 
 
IMNV Brazil viral isolation 
An IMNV isolate from Brazil was kindly provided by the Aquaculture Pathology Labora-
tory at the University of Arizona. Virus inoculum was clarified directly from frozen in-
fected samples as described previously (Loy et al., 2012). Shrimp (7–10 g) were injected 
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intramuscularly (100 μl) with 1:100 dilution of IMNV Brazil [~7.2 × 102 virus copies (μl 
RNA)–1] (Loy et al., 2012). Clinical signs of lethargy and white muscle were observed at 3 
days p.i. Moribund shrimp with gross lesions were collected for RNA extraction using a 
QIAGEN RNeasy Mini kit according to the manufacturer’s instructions. The RNA from 
shrimp infected with IMNV Brazil was tested by RT-PCR and sequence length was con-
firmed on a 1% agarose gel. 
 
Determination of novel dsRNA disease protection efficacy in vivo 
Shrimp (3–5 g) were divided into five groups of 10 shrimp with three replicates in each 
group and 10 shrimp for negative controls. Tanks were maintained at 29–30°C. Shrimp 
were injected intramuscularly with 5 μg per shrimp (100 μl) of dsRNA95-475, dsRNA26-
401, dsRNA233-613, and dsEGFP or 2% NaCl, and shrimp were injected at 48 h p.i. with 
2% NaCl (negative control group) or IMNV 1:100 dilution of IMNV Indonesia that reached 
95–100% mortality within 2 weeks [~2.11 × 103 virus copies (μl RNA)–1] (Loy et al., 2012). 
Shrimp were fed and mortality observed twice per day. Tissue samples from moribund or 
dead shrimp were stored in –80°C for further quantification of virus copy number. 
 
qRT-PCR 
qRT-PCR for assay virus load was adapted from a previously described method (Andrade 
et al., 2007). RNA was extracted using a RNeasy Mini kit (QIAGEN) and qRT-PCR was 
performed with conditions from a previous report (Loy et al., 2012). Each reaction was run 
in duplicate on a Bio-Rad CFX96 Real-Time PCR Detection System using a standard as 
described previously (Andrade et al., 2007; Loy et al., 2012). 
 
IMNV purification 
IMNV was purified using a combination of methods adapted from Mello et al. (2011) and 
Poulos & Lightner (2006). Briefly, 100 shrimp (7–10 g) were infected with a 1:100 dilution 
of IMNV Indonesia (Loy et al., 2012). Moribund shrimp were collected during a 2-week 
course of infection to obtain ~500 g abdominal muscle tissue from acutely infected animals. 
Heads were removed to reduce the amount of lipid input into the virus purification pro-
cess. Infected tissues were placed in 0.1 M PBS buffer, pH 7.5 plus 0.5 % of Na2SO4 (w/v) 
at a ratio of 1:3 and homogenized in a blender. Additionally, 10% chloroform (v/v) was 
added into the homogenate and was then centrifuged at 8000 g for 15 min to clarify the 
suspension. Following the first centrifugation, the supernatant was removed and centri-
fuged again to remove the tissue debris. The supernatant was collected and precipitated 
by adding 10% polyethylene glycol (w/v) and 4% NaCl (w/v), stirred at 4°C for 1 h, and 
centrifuged at 8000 g for 20 min at 4°C (Mello et al., 2011). The pellet was then resuspended 
and loaded onto 10–40% sucrose gradient and centrifuged at 70 000 g for 2 h at 4°C. A 
pellet was observed in the bottom of the ultracentrifuge tube at the 40% sucrose gradient. 
The virus pellet was removed from the ultracentrifuge tube and diluted in the same buffer 
to be stored at –80°C. The presence of virus was confirmed by RNA extraction and RT-
PCR. Purified virus also was injected intramuscularly into 7–10 g shrimp to confirm the 
virulence and presence of virus in the preparation. 
  
L O Y  E T  A L . ,  J O U R N A L  O F  G E N E R A L  V I R O L O G Y  9 6  (2 0 1 5 )  
14 
Northern blot analysis 
Northern blot analysis was performed using methods adapted from Brown et al. (2001) 
and the manufacturer’s instructions (NorthernMax-Gly; Life Technologies). Total RNA (5 
mg) was resolved on a 1% agarose glyoxal gel for 1 h at 100 V, alongside a biotinylated 
RNA molecular mass marker (Millennium Marker; Ambion). The gel was observed for the 
presence of RNA via ethidium bromide staining in a UV light box prior to transfer. Then 
the gel was nicked with 500 kJ UV light and transferred to a positively charged membrane 
(Whatman Nytran Supercharge TurboBlotter; Sigma Aldrich) using a passive downhill 
transfer technique for 1 h. Membranes were UV cross-linked at 1200 kJ and hybridized 
overnight in ULTRAhyb Ultrasensitive Hybridization Buffer (Ambion) at 68°C with bioti-
nylated RNA probes. Biotinylated RNA probes, including a probe to positions 95 (sense) 
and 475 (antisense), and to the new sequences at positions 233 (sense) and 613 (antisense) 
(Table S1), were generated using a BrightStar Psoralen-Biotin Nonisotopic Labelling kit 
(Ambion). PCR templates with T7 sequence at the 5′ ends were used to generate in vitro 
transcripts (T7 RNA polymerase; Promega). RNA transcripts were then labeled with biotin 
according to the manufacturer’s instruction (BrightStar Biotin-Psoralen kit). The hybrid-
ized membranes were developed following the manufacturer’s instruction and the signal 
was detected by chemiluminescence using a BrightStar BioDetect kit (Ambion). 
 
Statistical analysis 
Survival and qRT-PCR data were analyzed using one-way ANOVA followed by Tukey’s 
multiple comparison test (P < 0.05) using JMP Pro 10.0.0 software (SAS Institute). Survival 
data and viral copy number were expressed as the mean ± SEM. Mean survival data were 
tested at the termination of experiment on day 14 p.i. and the mean log viral copy number 
was compared between groups. 
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Supplemental Table and Figures: 
 
S1.  Sequence alignment of the originally published, 7,561 bp IMNV (Indonesia) genome 
sequence [EF061744.1] with full-length, 8,226 bp, genome sequence of IMNV (Indonesia) 
[KF836757.1] and IMNV (Brazil) [KJ556923.1].  Full-length sequence was generated based on 
RNA-seq and 5’ and 3’RACE using IMNV-infected shrimp cDNA.   Top) alignment of the 5’- end 
of the sequence shows 643 new bases of sequence preceding the originally published genome 
start site. Bottom) alignment of the 3’- end of the sequence shows 23 new bases of sequence 
succeeding the originally published genome end site. Sequences were subjected to Clustal 
Omega alignment (Sievers et al., 2011). *denotes strictly conserved nucleotide sequences. 
 
S2.  RT-PCR confirmation of the existence of novel IMNV sequences in both IMNV (Indonesia) 
and (Brazil) strain using four different sets of primers targeting the 5’-end (see Table S1). Lanes 
1-4 and 5-8 show PCR products from template generated from L. vannamei infected with IMNV 
(Indonesia) and (Brazil), respectively. RT-PCR products from lanes 1-4 and 5-8 are 331, 704, 
643 and 990 kb in length, respectively.  Lane 9 is amplicon from primers designed to the original 
IMNV sequence (95F, 475R, Table S1); M = Marker. These primers also were tested on RNA 
from uninfected, specific pathogen-free (SPF) shrimp; RT-PCR results were negative at a 
variety of cycling conditions for all primers using template from uninfected shrimp (data not 
shown). 
 
S3.  RT-PCR confirmation of novel sequences at 3’-end of IMNV genome. Primers were 
designed to specifically amplify to IMNV (Indonesia) [lanes 1 and 2] and (Brazil) [lanes 3 and 4]. 
Amplicons are 352 kb (lanes 1 and 3) and 358 kb (lanes 2 and 4) in size. These primers were 
tested with SPF shrimp cDNA and no amplification of virus was detected, indicating that 
sequences are present only in virus-infected tissues (data not shown). 
 
S4. Annotated nucleotide and predicted translation of additional sequence at the 5’- end of the 
IMNV genome.  The start site for the longest predicted ORF, in frame +1, is shown.  The 
predicted ORF1 has additional 114 aa at the N-terminus.  The nt sequence start from the 
original genome sequence, and originally predicted translation start site are denoted as 7561.  
Arrows also denote primers used to generate dsRNA for bioassays (see Table S1).  
 
S5.  Confirmation of suppression of IMNV replication in muscle tissue by qRT-PCR analysis. 
Virus load in animals subjected to dsRNA vaccines for novel and known regions of the IMNV 
genome.  qRT-PCR results are shown for log transformed total genome copy numbers as 
calculated from a standard curve.  X-axis is treatment and Y-axis is log10 viral genome copy 
number. Bars represent standard error within the sample. n=18 samples/treatment. 
  
Supplemental Table 1.  Oligonucleotide primer sequences for RT-PCR, dsRNA synthesis and 
RACE PCR 
 
Primers Sequence (5’- 3’) 
RT-PCR to confirm new IMNV genome sequence 
IMNV26F TTCGTAGGCAAGAACGAAGTGGCT 
IMNV312F GTAGCATTACTTGGCGCATGCAGT 
IMNV643R ACTATGTGGACATGACACAGGGCA 
IMNV1016R TGATTGTATGCTGCCACCTCCAGA 
IMNV8204R1 CGACTATAACCTAGGGCCAACCGC 
IMNV8210R2 GACTATAACCTAGGGCC 
IMNV7852F TTGGACAAATGGTTCCCGGTCCAA 
dsRNA synthesis* 
IMNV26T7F TAATACGACTCACTATAGGGTTCGTAGGCAAGAACGAAGTGGCT 
IMNV401T7R TAATACGACTCACTATAGGGTTCGCTATACGCCGAGGTTACAGT 
IMNV233T7F TAATACGACTCACTATAGGGACGAGTCGCATCCTTACGAGAAGT 
IMNV613T7R TAATACGACTCACTATAGGGTCTTACGTGAAGGACGAACGGGAA 
5’ RACE, IMNV (Indonesia) 
273F ACGAGTCGCATCCTTACGAGAAG 
452R AGACATCCAATGGTATATGGACAG 
428R TCCAGTTTCTAGCATACAAGCCGG 
C tail F GACATCGAAAGGGGGGGGGGG 
374R GCCGAGGTTACAGTCGGACTAG 
5’ RACE, IMNV (Brazil) 
51F GCTATGGGGTTTGAGGTTTAGCCG 
163R GAGAACAACAGCTAATCGAGGACG 
243R TACTGCACTTCTCGTAAGGATGCG 
304R AAGTAATGCTACCCGTAACGACGG 
3’ RACE , IMNV (Brazil) and (Indonesia) 
3’ RT GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTT 
3’ Rev GGCCACGCGTCGACTAGTA 
7945F GAAATTCCAACTGAACCAGCAGTT 
M13F GTAAAACGACGGCCAG 
M13R CAGGAAACAGCTATGAC 
* Underlined sequence corresponds to T7 primer added for in vitro transcription. 
 
 
 
  
Figure S2. 
 
  
 
Figure S3. 
 
  
Figure S4. 
                          26F 
TCTACATCTGGCCAAGGAAAATCTGTTCGTAGGCAAGAACGAAGTGGCTATGGGGTTTGAGGTTTAGCCG 
 
AAAGAGATCTCGACAGTCTTTAGTAGGATACACTTCTTACACTCCTGGGAAAGAGAAACATTATCTGTCC 
 
AGCAATGATACACGGGTACGTCCTCCATTAGCTGTTGTTTTCTTTTCCTCGGCAGGTCCTACAATGTCGG 
                       233F 
AGCGCAGGAACAGGACGAACCCACGAGTCGCATCCTTACGAGAAGTGCAGTAGGTTGGCGCTGTTGAGAG 
                                
CGGGTGATCTGGGTAATGTCCGTCGTTACGGGTAGCATTACTTGGCGCATGCAGTGGGAAGTCATGGCCC 
                            401R 
ACGTCACCTTAACAAAAGACTAGTCCGACTGTAACCTCGGCGTATAGCGAAAGCGGTTAGATAACATTAA 
                             
ATACCGGCTTGT ATG CTA GAA ACT GGA CTG TCC ATA TAC CAT TGG ATG TCT CAA ACA AAG  
               M   L   E   T   G   L   S   I   Y   H   W   M   S   Q   T   K 
 
AAT AAA GAA CCT GTT GTT GAA CAG CAA AAT CAA CAA ACC TTC AAC CAA AAA GAC CAC A 
 N   K   E   P   V   V   E   Q   Q   N   Q   Q   T   F   N   Q   K   D   H               
                                                                     613R 
AT GCG CTA GTG ATT GAA CAC AAA ACT AGT GCA ACA ACG AGC GCC CAA AGC ATT CCC GT  
N   A   L   V   I   E   H   K   T   S   A   T   T   S   A   Q   S   I   P   V 
                                643R                       7561  
T CGT CCT TCA CGT AAG AAG GAT GAC TAT GTG GAC ATG ACA CAG GGC AAT TTC AAC CTA 
   R   P   S   R   K   K   D   D   Y   V   D   M   T   Q   G   N   F   N   L   
     
ATT CTA AAA CTG TTA CCA ACA ATT TCT GAA CTA CAG AAG AGG CAT ATT CTT CAT CTA C 
 I   L   K   L   L   P   T   I   S   E   L   Q   K   R   H   I   L   H   L   
            95F     
TT CGA GAA GAA GTA GAA GGA AAG AAA GTT TGT TTC GTA AAG CGA GAA AAA CAG AAT CC 
L   R   E   E   V   E   G   K   K   V   C   F   V   K   R   E   K   Q   N   P   
        7561  
A CTT ATG GCT ATA AAC GAA CTA GCC GTT AAA GTT GGA GAG AAG CCT AAA TAC ACA TCG 
   L   M   A   I   N   E   L      A   V   K   V   G   E   K   P  K   Y   T   S 
 
ACGAAAACCGGAGCTGACCACATTCCAAGCTGGACTGTATTGGTTGAGTTCGCAGGTTTTAGCGAAGCAGCGACATG 
 
TGACACAGTTAAAAACGCAAAAATGATTGCTGCTTACAAATTAGTTAAAAGATTTTGTAAATGGGACCCAACCTACA 
 
TTGAAATTTCTGATTGTATGCTGCCACCTCCAGACCTTACATCGTGCGGGGACGTTGAGAGTAATCCTGGACCTATC 
                                 475R  
ATACATAGCGTTGCATTTGCAAGAACTGGTTCAGTATGGACACCTGCCACCTTTACTTTCAATACTACATCATCCCC 
Figure S5. 
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